Retarutide (LY3437943) is a triple agonist peptide of glucagon receptor (GCGR), glucose-dependent insulin-promoting peptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R)
HUBERMAN: So there's a real logic here, but what we haven't really addressed is if one has an injury, let's say to the hand, or to the arm, or to the leg, or to the ankle, or to the Achilles tendon, How is it that body protection compound that normally would exist within the gut actually access that injured tissue
Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high fat diet-induced obesity in mice
The most performance-relevant outcome is improved oxygen delivery, because B12 deficiency directly causes anemia and reduced VO2 max regardless of training
It does not indicate a problem with the peptide itself
The thymus starts to atrophy around age 15 and continues to decline until approximately 80-90% of its activity has decreased by age 35-45, which is when the chronic diseases of aging start becoming prevalent